Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

37 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

End of Study Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - End of Study Psoriasis MIPSO EudraCT 2014-003022-40

- 25/7/16 - 1 formulario, 1 itemgroup, 5 items, 1 idioma
Itemgroup: End of Study
MIPSO Comparative study of bacterial microbiota in the skin and intestines of psoriasis patients before and after systemic treatment with adalimumab or ustekinumab or ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. H. C. Thomas A. Luger

Ciclosporin Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Ciclosporin Psoriasis MIPSO EudraCT 2014-003022-40

- 25/7/16 - 1 formulario, 2 itemgroups, 9 items, 1 idioma
Itemgroups: Cyclosporine, Cyclosporine medication
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Eligibility Determination Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Eligibility Determination Psoriasis MIPSO EudraCT 2014-003022-40

- 23/7/16 - 1 formulario, 6 itemgroups, 54 items, 2 idiomas
Itemgroups: Patient identification, Inclusion criteria, Exclusion criteria, Additional exclusion criteria Adalimumab, Additional exclusion criteria Ustekinumab, Additional exclusion criteria Cyclosporine
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Medical History Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Medical History Psoriasis MIPSO EudraCT 2014-003022-40

- 23/7/16 - 1 formulario, 2 itemgroups, 6 items, 1 idioma
Itemgroups: Prior diseases, Prior diseases
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Adverse Event Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Adverse Event Psoriasis MIPSO EudraCT 2014-003022-40

- 23/7/16 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Adverse Event, Adverse Event Questionaire
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Demographics Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Demographics Psoriasis MIPSO EudraCT 2014-003022-40

- 23/7/16 - 1 formulario, 1 itemgroup, 10 items, 1 idioma
Itemgroup: Demographics
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Adalimumab/Ustekinumab Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - Adalimumab/Ustekinumab Psoriasis MIPSO EudraCT 2014-003022-40

- 23/7/16 - 1 formulario, 2 itemgroups, 7 items, 1 idioma
Itemgroups: Adalimumab/Ustekinumab, Medication Adalimumab/Ustekinumab
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Personal and Family History of Psoriasis Protocol PhenX Toolkit

- 26/4/16 - 1 formulario, 1 itemgroup, 28 items, 1 idioma
Itemgroup: PhenX - personal and family history of psoriasis protocol
The Self Evaluation plus Medication Survey is a self-administered instrument which was developed from the questionnaires used in the Collaborative Association Study of Psoriasis (CASP), which is a Genetic Association Information Network (GAIN) genome-wide association study (GWAS). The Self Evaluation plus Medication Survey collects information on individuals with psoriasis and controls, and their family history of psoriasis and other autoimmune diseases. Additionally, for individuals with psoriasis the questionnaire collects information regarding their symptoms and medication use and its effectiveness. ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

End of Study Psoriasis MIPSO EudraCT 2014-003022-40 DRKS00007147 - End of Study Psoriasis MIPSO EudraCT 2014-003022-40

- 26/8/15 - 1 formulario, 2 itemgroups, 21 items, 2 idiomas
Itemgroups: End of Study, Studienabbruch Grund RQG
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger

Eligibility Psoriasis NCT00216879

- 9/7/15 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis ODM derived from http://clinicaltrials.gov/ct2/show/NCT00148213?term=NCT00148213&rank=1

Eligibility NCT00233662 Chronic Plaque Psoriasis - Eligibility

- 13/4/14 - 1 formulario, 3 itemgroups, 32 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria, Medical Concepts
ODM derived from http://clinicaltrials.gov/show/NCT00233662

Eligibility NCT00333411 Psoriasis - Eligibility

- 13/4/14 - 1 formulario, 3 itemgroups, 53 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria, Medical Concepts
ODM derived from http://clinicaltrials.gov/show/NCT00333411

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial